Hemodialysis Access Promise from Polymer Implant
Netherlands and US-based medtech company Xeltis tells us about its first-in-human (FIH) vascular conduit trial for hemodialysis access. Vascular surgeon Prof. Dr. Frans Moll presented the data at the 50thAnnual VEITH symposium in New York. In a subsequent news release the company describes the...
Latest News
Orthopedic Device Market to Grow by USD 12.11 Bn Between 2022 and 2027 Says New Report
Global technology research and advisory company Technavio says the market size for orthopedic...
read the full article >